Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
28.87
+0.26 (0.91%)
Dec 11, 2025, 4:00 PM EST
TKPHF Market Cap
TKPHF has a market cap or net worth of $46.1 billion as of December 16, 2025. Its market cap has increased by 8.02% in one year.
Market Cap
46.10B
Enterprise Value
75.23B
Revenue
29.85B
Ranking
n/a
PE Ratio
206.26
Stock Price
$28.87
Market Cap Chart
Since January 14, 1992, TKPHF's market cap has increased from 8.47B to 46.10B, an increase of 444.13%. That is a compound annual growth rate of 5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 46.10B | 9.32% |
| Dec 30, 2024 | 42.17B | -6.54% |
| Dec 29, 2023 | 45.12B | -6.90% |
| Dec 30, 2022 | 48.46B | 14.20% |
| Dec 30, 2021 | 42.44B | -25.32% |
| Dec 30, 2020 | 56.83B | -8.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |